Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient

Clin Rheumatol. 2007 Jun;26(6):1023-4. doi: 10.1007/s10067-006-0263-9. Epub 2006 Mar 30.

Abstract

With the broad employment of immunosuppressive therapy, the incidence of Pseudallescheria boydii infections is rising. We report a first case of the localized subcutaneous P. boydii infection in a patient with microscopic polyangiitis. Favorable outcome related to the treatment with voriconazole adds to the growing body of evidence supporting the use of this particular agent in P. boydii infections.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Humans
  • Immunocompromised Host*
  • Male
  • Methylprednisolone / adverse effects*
  • Middle Aged
  • Mycetoma / immunology*
  • Pseudallescheria / immunology*
  • Pseudallescheria / pathogenicity
  • Vasculitis / drug therapy
  • Vasculitis / microbiology

Substances

  • Anti-Inflammatory Agents
  • Methylprednisolone